Clinical Trial Update: Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dalbavancin versus standard of care for completion of treatment in complicated bacteremia or infective endocarditis; study terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Endocarditis

Drugs mentioned

• Dalbavancin (dalbavancin)

Snippet

Sponsor: AbbVie | Conditions: Endocarditis, Bacteremia | Phase 2 | Status: TERMINATED | Results posted: 2018-09-10